Pamela Martyn-Nemeth1, Sarah Schwarz Farabi2, Dan Mihailescu3, Jeffrey Nemeth4, Laurie Quinn5. 1. University of Illinois at Chicago, College of Nursing, Department of Biobehavioral Health Science, 845S. Damen Ave. (MC 802), Chicago, IL 60612. Electronic address: pmartyn@uic.edu. 2. University of Illinois at Chicago, College of Nursing, Department of Biobehavioral Health Science, 845S. Damen Ave. (MC 802), Chicago, IL 60612. Electronic address: sschwa24@uic.edu. 3. University of Illinois at Chicago, Department of Medicine, Chicago, IL 60612. Electronic address: danmih@uic.edu. 4. Linden Oaks, Edward Hospital and Health Center, Naperville, IL 60540. Electronic address: jeffreymnemeth@lewisu.edu. 5. University of Illinois at Chicago, College of Nursing, Department of Biobehavioral Health Science, 845S. Damen Ave. (MC 802), Chicago, IL 60612. Electronic address: lquinn1@uic.edu.
Abstract
PURPOSE: This review summarizes the current state of the science related to fear of hypoglycemia (FOH) in adults with type 1 diabetes. Fear of hypoglycemia is a critical deterrent to diabetes self-management, psychological well-being, and quality of life. We examine the influence of contemporary treatment regimens, technology, and interventions to identify gaps in knowledge and opportunities for research and practice. BASIC PROCEDURES: A literature search was conducted of MEDLINE, PsycINFO, and EMBASE. Fifty-three studies that examined fear of hypoglycemia were included. MAIN FINDINGS: Fear of hypoglycemia influences diabetes management and quality of life. Gender and age differences exist in experiences and responses. Responses vary from increased vigilance to potentially immobilizing distress. Fear of hypoglycemia is greater at night and may contribute to poor sleep quality. Strategies to reduce fear of hypoglycemia have had varying success. Newer technologies hold promise but require further examination. CONCLUSIONS: Fear of hypoglycemia remains a problem, despite advances in technology, insulin analogs, and evidence-based diabetes management. Clinical care should consistently include assessment for its influence on diabetes self-management and psychological health. Further research is needed regarding the influence of newer technologies and individualized strategies to reduce fear of hypoglycemia while maintaining optimal glucose control.
PURPOSE: This review summarizes the current state of the science related to fear of hypoglycemia (FOH) in adults with type 1 diabetes. Fear of hypoglycemia is a critical deterrent to diabetes self-management, psychological well-being, and quality of life. We examine the influence of contemporary treatment regimens, technology, and interventions to identify gaps in knowledge and opportunities for research and practice. BASIC PROCEDURES: A literature search was conducted of MEDLINE, PsycINFO, and EMBASE. Fifty-three studies that examined fear of hypoglycemia were included. MAIN FINDINGS: Fear of hypoglycemia influences diabetes management and quality of life. Gender and age differences exist in experiences and responses. Responses vary from increased vigilance to potentially immobilizing distress. Fear of hypoglycemia is greater at night and may contribute to poor sleep quality. Strategies to reduce fear of hypoglycemia have had varying success. Newer technologies hold promise but require further examination. CONCLUSIONS: Fear of hypoglycemia remains a problem, despite advances in technology, insulin analogs, and evidence-based diabetes management. Clinical care should consistently include assessment for its influence on diabetes self-management and psychological health. Further research is needed regarding the influence of newer technologies and individualized strategies to reduce fear of hypoglycemia while maintaining optimal glucose control.
Authors: Morey W Haymond; Maria J Redondo; Siripoom McKay; Martin J Cummins; Brett Newswanger; John Kinzell; Steven Prestrelski Journal: Diabetes Care Date: 2016-02-09 Impact factor: 19.112
Authors: Eric D Foster; Nancy D Bridges; Irene D Feurer; Thomas L Eggerman; Lawrence G Hunsicker; Rodolfo Alejandro Journal: Diabetes Care Date: 2018-03-21 Impact factor: 19.112
Authors: Shana O Warner; Abby M Wadian; Marta Smith; Ben Farmer; Yufei Dai; Nicole Sheanon; Dale S Edgerton; Jason J Winnick Journal: Am J Physiol Endocrinol Metab Date: 2021-03-29 Impact factor: 4.310
Authors: Scott J Pilla; Jenny Park; Jessica L Schwartz; Michael C Albert; Patti L Ephraim; L Ebony Boulware; Nestoras N Mathioudakis; Nisa M Maruthur; Mary Catherine Beach; Raquel C Greer Journal: J Gen Intern Med Date: 2021-01-21 Impact factor: 6.473
Authors: Mary Courtney Moore; Shana O Warner; Yufei Dai; Nicole Sheanon; Marta Smith; Ben Farmer; Rebecca L Cason; Alan D Cherrington; Jason J Winnick Journal: JCI Insight Date: 2021-06-22